No Data
"When will the 'medication' market return? Foreign capital and public offerings are racing to buy these pharmaceutical stocks.
The pharmaceutical industry has always been recognized as a "long slope and thick snow" track, and it is also one of the sectors that capital markets pay the most attention to.
hec cj pharm (01558) and 3sbio (01530) affiliated signed an authorization agreement related to the license of Benzoate Crizotinib.
Hec cj pharm (01558) and the offeror Guangdong hec technology holding jointly announced regarding the offeror...
Express News | Six institutions: improve the management of grassroots pharmaceuticals and expand the types of grassroots pharmaceuticals.
The bullish market stimulated the Hong Kong stock pharmaceutical sector, with Laikai Pharmaceutical soaring nearly 20%.
Statistics from the Capital Research Department of Silver (Hong Kong) show that the number of innovative drugs IND and NDA has returned to growth after hitting a low in 2022. In the third quarter of this year, 1033 drug clinical approvals were granted, a 25% year-on-year increase, with a total of 8 first-class innovative drugs approved for marketing, doubling year-on-year.
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
Yichang HEC Changjiang Pharmaceutical's Merger Offeror Agreed to License-out Product for $938 Million
No Data
No Data